Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer

Anne Sofie Brems-Eskildsen, Søren Linnet, Hella Danø, Adam Luczak, Peter Michael Vestlev, Erik Hugger Jakobsen, Jeppe Neimann, Charlotte Buch Jensen, Trine Dongsgaard, Sven Tyge Langkjer

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Fingeraftryk

Udforsk hvilke forskningsemner 'Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer' indeholder.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science